Phase 2 Start~month

Phase 2 Start: A Phase 2b, Randomized, Placebo-controlled, Double-blind, Dose-ranging Trial to Assess the Efficacy

Indication
Fibrostenotic Crohn's Disease

Other upcoming events for AGMB

Phase 1 StartPhase 1 Start: An Open-label, Two-part Trial to Assess the Mass-balance Recovery, Metabolite Profile, Metabolite Id

Track this catalyst and more

Get real-time alerts, AI-powered analysis, and full catalyst coverage.

Start FreeFull Calendar
    Phase 2 Start: A Phase 2b, Randomized, Placebo-controlled, Double-blind, Dose-ranging Trial to Assess the Efficacy — AGMB Phase 2 Start | BioSniper